JPH0249711A - Novel cream for foundation cosmetic - Google Patents
Novel cream for foundation cosmeticInfo
- Publication number
- JPH0249711A JPH0249711A JP63198941A JP19894188A JPH0249711A JP H0249711 A JPH0249711 A JP H0249711A JP 63198941 A JP63198941 A JP 63198941A JP 19894188 A JP19894188 A JP 19894188A JP H0249711 A JPH0249711 A JP H0249711A
- Authority
- JP
- Japan
- Prior art keywords
- sodium
- montmorillonite
- sodium montmorillonite
- oils
- complex
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000006071 cream Substances 0.000 title abstract description 7
- 239000002537 cosmetic Substances 0.000 title abstract description 6
- GUJOJGAPFQRJSV-UHFFFAOYSA-N dialuminum;dioxosilane;oxygen(2-);hydrate Chemical compound O.[O-2].[O-2].[O-2].[Al+3].[Al+3].O=[Si]=O.O=[Si]=O.O=[Si]=O.O=[Si]=O GUJOJGAPFQRJSV-UHFFFAOYSA-N 0.000 claims abstract description 25
- 239000004094 surface-active agent Substances 0.000 claims abstract description 10
- 239000003921 oil Substances 0.000 claims abstract description 8
- 230000000694 effects Effects 0.000 claims abstract description 7
- 235000019198 oils Nutrition 0.000 claims abstract description 7
- CYDQOEWLBCCFJZ-UHFFFAOYSA-N 4-(4-fluorophenyl)oxane-4-carboxylic acid Chemical compound C=1C=C(F)C=CC=1C1(C(=O)O)CCOCC1 CYDQOEWLBCCFJZ-UHFFFAOYSA-N 0.000 claims abstract description 4
- 230000009471 action Effects 0.000 claims abstract description 4
- 239000001540 sodium lactate Substances 0.000 claims abstract description 4
- 229940005581 sodium lactate Drugs 0.000 claims abstract description 4
- 235000011088 sodium lactate Nutrition 0.000 claims abstract description 4
- 235000015112 vegetable and seed oil Nutrition 0.000 claims abstract description 4
- 102000008186 Collagen Human genes 0.000 claims abstract description 3
- 108010035532 Collagen Proteins 0.000 claims abstract description 3
- 102000016942 Elastin Human genes 0.000 claims abstract description 3
- 108010014258 Elastin Proteins 0.000 claims abstract description 3
- 229920001436 collagen Polymers 0.000 claims abstract description 3
- 229920002549 elastin Polymers 0.000 claims abstract description 3
- 235000019165 vitamin E Nutrition 0.000 claims abstract description 3
- 239000011709 vitamin E Substances 0.000 claims abstract description 3
- PRAKJMSDJKAYCZ-UHFFFAOYSA-N squalane Chemical compound CC(C)CCCC(C)CCCC(C)CCCCC(C)CCCC(C)CCCC(C)C PRAKJMSDJKAYCZ-UHFFFAOYSA-N 0.000 claims abstract 4
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 claims abstract 3
- 239000004202 carbamide Substances 0.000 claims abstract 3
- 102000053602 DNA Human genes 0.000 claims abstract 2
- 108020004414 DNA Proteins 0.000 claims abstract 2
- ONIBWKKTOPOVIA-BYPYZUCNSA-N L-Proline Chemical compound OC(=O)[C@@H]1CCCN1 ONIBWKKTOPOVIA-BYPYZUCNSA-N 0.000 claims abstract 2
- 229930182821 L-proline Natural products 0.000 claims abstract 2
- 241001465754 Metazoa Species 0.000 claims abstract 2
- 241000772415 Neovison vison Species 0.000 claims abstract 2
- 239000003925 fat Substances 0.000 claims abstract 2
- 229940087559 grape seed Drugs 0.000 claims abstract 2
- JXTPJDDICSTXJX-UHFFFAOYSA-N n-Triacontane Natural products CCCCCCCCCCCCCCCCCCCCCCCCCCCCCC JXTPJDDICSTXJX-UHFFFAOYSA-N 0.000 claims abstract 2
- 229960002429 proline Drugs 0.000 claims abstract 2
- 229940032094 squalane Drugs 0.000 claims abstract 2
- 229940045136 urea Drugs 0.000 claims abstract 2
- 230000003020 moisturizing effect Effects 0.000 claims description 7
- 239000008278 cosmetic cream Substances 0.000 claims description 6
- 238000004519 manufacturing process Methods 0.000 claims description 6
- 229920002101 Chitin Chemical class 0.000 claims description 5
- 229910052901 montmorillonite Inorganic materials 0.000 claims description 4
- 102000004196 processed proteins & peptides Human genes 0.000 claims description 4
- 108090000765 processed proteins & peptides Proteins 0.000 claims description 4
- 229920001184 polypeptide Polymers 0.000 claims description 3
- 230000004913 activation Effects 0.000 claims description 2
- 239000000835 fiber Substances 0.000 claims description 2
- 229940045920 sodium pyrrolidone carboxylate Drugs 0.000 claims description 2
- HYRLWUFWDYFEES-UHFFFAOYSA-M sodium;2-oxopyrrolidine-1-carboxylate Chemical compound [Na+].[O-]C(=O)N1CCCC1=O HYRLWUFWDYFEES-UHFFFAOYSA-M 0.000 claims description 2
- 239000008158 vegetable oil Substances 0.000 claims description 2
- 241000283690 Bos taurus Species 0.000 claims 2
- 238000000354 decomposition reaction Methods 0.000 claims 2
- 230000002255 enzymatic effect Effects 0.000 claims 2
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical class CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 claims 2
- 244000020518 Carthamus tinctorius Species 0.000 claims 1
- 235000003255 Carthamus tinctorius Nutrition 0.000 claims 1
- 244000020551 Helianthus annuus Species 0.000 claims 1
- 235000003222 Helianthus annuus Nutrition 0.000 claims 1
- 108010076876 Keratins Chemical class 0.000 claims 1
- 102000011782 Keratins Human genes 0.000 claims 1
- 240000007817 Olea europaea Species 0.000 claims 1
- 244000025272 Persea americana Species 0.000 claims 1
- 235000008673 Persea americana Nutrition 0.000 claims 1
- 244000044822 Simmondsia californica Species 0.000 claims 1
- 235000004433 Simmondsia californica Nutrition 0.000 claims 1
- 229920002385 Sodium hyaluronate Polymers 0.000 claims 1
- 235000013877 carbamide Nutrition 0.000 claims 1
- 210000004207 dermis Anatomy 0.000 claims 1
- 150000004676 glycans Chemical class 0.000 claims 1
- 150000002334 glycols Chemical class 0.000 claims 1
- 239000004310 lactic acid Chemical class 0.000 claims 1
- 235000014655 lactic acid Nutrition 0.000 claims 1
- 229960000448 lactic acid Drugs 0.000 claims 1
- 210000003041 ligament Anatomy 0.000 claims 1
- 229920000642 polymer Polymers 0.000 claims 1
- 229920001282 polysaccharide Polymers 0.000 claims 1
- 239000005017 polysaccharide Substances 0.000 claims 1
- 210000003491 skin Anatomy 0.000 claims 1
- 229940010747 sodium hyaluronate Drugs 0.000 claims 1
- YWIVKILSMZOHHF-QJZPQSOGSA-N sodium;(2s,3s,4s,5r,6r)-6-[(2s,3r,4r,5s,6r)-3-acetamido-2-[(2s,3s,4r,5r,6r)-6-[(2r,3r,4r,5s,6r)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2- Chemical compound [Na+].CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 YWIVKILSMZOHHF-QJZPQSOGSA-N 0.000 claims 1
- 239000000203 mixture Substances 0.000 abstract description 8
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 abstract description 6
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 abstract description 4
- 239000002253 acid Substances 0.000 abstract description 4
- 230000001804 emulsifying effect Effects 0.000 abstract description 3
- 229930003427 Vitamin E Natural products 0.000 abstract description 2
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 abstract description 2
- 238000000034 method Methods 0.000 abstract description 2
- 230000008719 thickening Effects 0.000 abstract description 2
- 229940046009 vitamin E Drugs 0.000 abstract description 2
- 239000000126 substance Substances 0.000 abstract 2
- 230000003213 activating effect Effects 0.000 abstract 1
- 235000019197 fats Nutrition 0.000 abstract 1
- 208000017520 skin disease Diseases 0.000 abstract 1
- 230000008961 swelling Effects 0.000 abstract 1
- 235000019871 vegetable fat Nutrition 0.000 abstract 1
- 238000009736 wetting Methods 0.000 abstract 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 4
- 229920002125 Sokalan® Polymers 0.000 description 4
- 239000000839 emulsion Substances 0.000 description 4
- 238000009472 formulation Methods 0.000 description 4
- 229940119170 jojoba wax Drugs 0.000 description 4
- 229910052708 sodium Inorganic materials 0.000 description 4
- 239000011734 sodium Substances 0.000 description 4
- 125000002057 carboxymethyl group Chemical group [H]OC(=O)C([H])([H])[*] 0.000 description 3
- ODHCTXKNWHHXJC-UHFFFAOYSA-N 5-oxoproline Chemical compound OC(=O)C1CCC(=O)N1 ODHCTXKNWHHXJC-UHFFFAOYSA-N 0.000 description 2
- 229930091371 Fructose Natural products 0.000 description 2
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 2
- 239000005715 Fructose Substances 0.000 description 2
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 2
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 2
- 150000002148 esters Chemical class 0.000 description 2
- 239000008103 glucose Substances 0.000 description 2
- 239000004615 ingredient Substances 0.000 description 2
- 239000008213 purified water Substances 0.000 description 2
- 230000037380 skin damage Effects 0.000 description 2
- 239000008279 sol Substances 0.000 description 2
- ODHCTXKNWHHXJC-VKHMYHEASA-N 5-oxo-L-proline Chemical compound OC(=O)[C@@H]1CCC(=O)N1 ODHCTXKNWHHXJC-VKHMYHEASA-N 0.000 description 1
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 1
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 1
- YJUFCXMAKCLEJZ-UHFFFAOYSA-N [C].N1C(CCC1)=O Chemical compound [C].N1C(CCC1)=O YJUFCXMAKCLEJZ-UHFFFAOYSA-N 0.000 description 1
- 230000037374 absorbed through the skin Effects 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 239000012190 activator Substances 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 229910000278 bentonite Inorganic materials 0.000 description 1
- 239000000440 bentonite Substances 0.000 description 1
- SVPXDRXYRYOSEX-UHFFFAOYSA-N bentoquatam Chemical compound O.O=[Si]=O.O=[Al]O[Al]=O SVPXDRXYRYOSEX-UHFFFAOYSA-N 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 239000003974 emollient agent Substances 0.000 description 1
- 238000004945 emulsification Methods 0.000 description 1
- 239000010433 feldspar Substances 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 239000003531 protein hydrolysate Substances 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 229940079889 pyrrolidonecarboxylic acid Drugs 0.000 description 1
- 230000036620 skin dryness Effects 0.000 description 1
- 159000000000 sodium salts Chemical class 0.000 description 1
- 239000000600 sorbitol Substances 0.000 description 1
- 239000004575 stone Substances 0.000 description 1
- 230000009974 thixotropic effect Effects 0.000 description 1
- 230000007704 transition Effects 0.000 description 1
Abstract
Description
【発明の詳細な説明】 ［産業上の利用分野］ 本発明は、基礎化粧品のクリームとその製造に関する。[Detailed description of the invention] [Industrial application field] The present invention relates to a basic cosmetic cream and its production.
［従来の技術］
従来から、基礎化粧品の各種クリームは、油性分原料を
水分原料と混合したエマルジョンであるが、すべて表面
活性剤を使用して０／Ｗ 型または、Ｗｌｏ 型のエ
マルジョンとしている。ここに使用される表面活性剤の
量はｔＸ〜５＄ であり、この量はすべて皮膚の上にと
どまり、皮膚の障害をまったく起さないものではない、
ある部分は皮膚より吸収され、毛細血管にいたり血液に
移行する［発明が解決しようとする問題点］
基礎化粧品に使用される表面活性剤をまったく除去して
基礎化粧品のクリームを得ることができれば１表面活性
剤による皮膚障害を考慮する必要がない。[Prior Art] Conventionally, various creams for basic cosmetics are emulsions in which oily ingredients are mixed with water ingredients, and all of them use surfactants to form 0/W type or Wlo type emulsions. The amount of surfactant used here is tX~5$, which all stays on the skin and does not cause any skin damage.
A certain portion is absorbed through the skin, enters the capillaries, and transfers to the blood [Problem to be solved by the invention] If it is possible to obtain a cream for basic cosmetics by completely removing the surfactant used in basic cosmetics, 1 There is no need to consider skin damage caused by surfactants.
この問題点は、基礎化粧品の製造技術上不可俺とされて
いたことである。The problem with this is that it was considered impossible due to the manufacturing technology of basic cosmetics.
［発明の構成］
本発明はソジウム・モンモリロナイトの水膨潤ゲルの包
接作用を利用して、油成分を分散乳化することが基本で
あり、さらに、請求範囲３）、および４）の各組成物と
ソジウム・モンモリロナイトの複合体を生成して湿潤、
保水、増粘、皮膚賦活を与えることをもって、その構成
とする。[Structure of the Invention] The present invention is based on dispersing and emulsifying an oil component by utilizing the clathration effect of a water-swollen gel of sodium montmorillonite, and furthermore, each composition of claims 3) and 4) and wet by forming a complex of sodium montmorillonite,
Its composition includes water retention, thickening, and skin activation.
［ＩＦ！１題点を解決する手段］
本発明は、ソジウム・モンモリロナイトの研究の成果よ
り生れたものである。ソジウム・モンモリロナイトはベ
ントナイト原鉱を粉砕して水に投じ実質０．５〜１．５
％の希薄なゾルを作る。これによりソジウム・モンモ
リロナイトは膨潤して分散し原鉱に随伴、介在する石芙
、長石を主とする。[IF! Means for solving one problem] The present invention was born from the results of research on sodium montmorillonite. Sodium montmorillonite is made by crushing bentonite raw ore and pouring it into water to produce an actual 0.5 to 1.5
Make a dilute sol of %. As a result, the sodium montmorillonite swells and disperses, and is mainly composed of staghorn and feldspar that accompany and interpose the ore.
いわゆるシルトは沈降する。原鉱によって区区ではある
がシルトの沈降、分離は２４時間〜４８時間である。こ
のゾルを濠縮して実質［１％−１０２のゲルを得る。こ
のゲルをベースとして、植物性油としてたとえば、ホホ
バ油、エラセンシード油等を５ｚ・〜８ｚを混合して、
均一０／Ｗ型エマルジヨンを得ることができる。The so-called silt settles out. Although it depends on the raw ore, it takes 24 to 48 hours for the silt to settle and separate. This sol is mulched to obtain a gel of substantial [1%-102]. Using this gel as a base, mix 5z to 8z of vegetable oil such as jojoba oil, eracene seed oil, etc.
A uniform O/W type emulsion can be obtained.
混合の際に機械的シアーを適宜与へることはその作業を
容易にはするが、表面活性剤を使用する必要はない、ソ
ジウム・モンモリロナイトの包接作用によって充分なエ
マルジョンを得ることができるのである。Appropriate mechanical shear during mixing makes the process easier, but there is no need to use a surfactant, as a sufficient emulsion can be obtained through the inclusion action of sodium-montmorillonite. be.
本発明は、表面活性剤をまったく使用しない基礎化粧用
クリームで油性分を低めにおさえ、むしろ湿潤作用、保
湿作用を強調した新規な製品を提供するものである。The present invention provides a new product that is a basic cosmetic cream that does not use any surfactants, has a low oil content, and emphasizes moisturizing and moisturizing effects.
すなはち、１）皮膚に存在するピロリドンカルボン酸ソ
ーダを配合して豊富ならしめ、さらに、ソジウム・モン
モリロナイトを微酸性に移行させコントロールするため
に、ピロリドンカルボン酸をもっておこない結果として
、そのソーダ塩をもたらす、−石二鳥の処方を開発した
。In other words, 1) In order to enrich the sodium pyrrolidone carboxylate that exists in the skin, and to control the transition of sodium montmorillonite to a slightly acidic state, we added pyrrolidone carboxylic acid and as a result, the sodium salt We have developed a formula that will bring you two birds in one stone.
さらに、２）湿潤効果をもたらすために、むしろ吸湿作
用をもつアミノ酸であるし一プロリン、を配し、乳酸ナ
トリウムやソルビット、蛋白加水分解液をもって補強し
た処方を開発した。Furthermore, 2) in order to provide a moisturizing effect, we developed a formulation in which monoproline, an amino acid with a hygroscopic effect, was added and reinforced with sodium lactate, sorbitol, and protein hydrolyzate.
また、３）カルボキシメチルキチンのソジウム・モンモ
リロナイト複合体の添加による保水性の付与、ならびに
、絹フィブロイン・ソジウム会モンモリロナイト複合体
によるエモリエント効果の付与を強固にすることを目的
とする処方を開発した。在来のクリームは皮膚のかさつ
きに対処しようとして、いたずらは、油性分を増加し乳
化を維持するために１表面活性剤を増加してさた傾向に
あり油分のｒごとざと１した仕上りとなる傾向であった
。これに対して、本発明は、ソジウム・モンモリロナイ
トを使用して、油性分を均一分散し、表面活性剤をまっ
たく使用せず、さらに、１）２）３）にあげるように、
各種の製剤をソジウム・モンモリロナイト複合体として
添加するか、または、その系の中に生成せしめてなる、
特異の処方による基礎化粧用クリームであり、その製造
法である。In addition, 3) a formulation was developed that aims to strengthen the imparting of water retention by adding a sodium-montmorillonite complex of carboxymethyl chitin and the imparting of an emollient effect by the silk fibroin-sodium-montmorillonite complex. Conventional creams, in an attempt to combat skin dryness, tend to increase the oil content and increase the amount of surfactants to maintain emulsification, resulting in a coarser finish for each oil content. It was a trend. In contrast, the present invention uses sodium montmorillonite to uniformly disperse oily components, does not use any surfactants, and furthermore, as mentioned in 1) 2) and 3),
Various preparations are added as a sodium-montmorillonite complex, or formed in the system.
This is a basic cosmetic cream with a unique formulation and its manufacturing method.
さらに、ソジウム拳モンモリロナイト水膨潤ゲルの複合
体は、クリームとして顔面にぬり広げるときチキソトロ
ピー性を発揮して容易に粘度を低下して薄く、広く延展
する特性があることは、クリームとして、効果的である
が、ここにカルボキシビニルポリマーの微量の添加はざ
らに増粘効果を得ることができる。Furthermore, when the Sodium Fist Montmorillonite water-swelling gel complex is spread on the face as a cream, it exhibits thixotropic properties and easily lowers its viscosity to spread thinly and widely, making it effective as a cream. However, the addition of a small amount of carboxyvinyl polymer can significantly increase the viscosity.
［実施例］
処方ｌ
ソジウム・モンモリロナイト ５．０〜Ｂ、５１．
３−ブチレンゲリコール ３．０〜０．４パラ
オキシ安息香酸エステル ０．２〜０．３ｄｌ−ピ
ロリドンカルボン酸
ｄｌ−ピロリドンカルボン酸ソーダ
ホホバ油そのだの油性分
天然ビタミンＥ
プロチュ１００及び２００（味の素）
ヒアルロン酸ナトリウム
カルボキシビニルポリマー
精製水
処方２
ソジウム・モンモリロナイト
１．３−ブチレングリコール
バラオキシ安息香酸エステル
エラスチン（４ｚ）
ｌ−プロリン
カルボキシメチルキチン
コラーゲン（２ｚ）
ホホバ油その他の油性分
グルコースとフラクトース
カルボキシビニルポリマー
精製水
０．３〜０．４
１．５〜２．５
５．０〜Ｂ、５
０．３〜０．６
４．０〜Ｇ、０
０．１〜０．２
＜ ０．０１
バランス
５．０〜Ｂ、５
３．０〜４．０
０．２〜０．３
１．０〜２．０
０．５〜１．５
４．０〜θ、０
３．０〜４．５
４．０〜５．０
３．５〜４．５
＜ ０．０１
バランス
処方３
ソジウム・モンモリロナイト ５．０〜６．５１
．３−ブチレンゲリコール ２．０〜３．０バ
ラオキシ安息香酸エステル ０．２〜０．３ホホバ
油その他の油性分 ４．０〜５．０絹繊維由来
のポリペプタイド ５．５〜８．０カルボキシメチ
ルキチン ３．０〜４．５乳酸ナトリウム
３．０〜４．５ピロリドンカルボン醜
１．７〜２．３
グルコースとフラクトース ３．５〜４．５カ
ルボキシビニルポリマー
精製水 バランス上記の各
処方には、いずれも油性分の乳化のための表面活性剤は
使用していない。[Example] Prescription 1 Sodium montmorillonite 5.0-B, 51.
3-Butylene gellicol 3.0-0.4 paraoxybenzoic acid ester 0.2-0.3 dl-pyrrolidonecarboxylic acid dl-pyrrolidonecarboxylic acid Sodium jojoba oil Natural vitamin E Prochu 100 and 200 (Ajinomoto) Hyaluron Acid Sodium Carboxy Vinyl Polymer Purified Water Formula 2 Sodium Montmorillonite 1.3-Butylene Glycol Baroxybenzoate Elastin (4z) l-Proline Carboxymethyl Chitin Collagen (2z) Jojoba Oil and Other Oily Contents Glucose and Fructose Carboxy Vinyl Polymer Purification Water 0.3-0.4 1.5-2.5 5.0-B, 5 0.3-0.6 4.0-G, 0 0.1-0.2 < 0.01 Balance 5. 0-B, 5 3.0-4.0 0.2-0.3 1.0-2.0 0.5-1.5 4.0-θ, 0 3.0-4.5 4.0 ~5.0 3.5~4.5 < 0.01 Balance Prescription 3 Sodium Montmorillonite 5.0~6.51
．． 3-Butylene gellicol 2.0-3.0 Roseoxybenzoic acid ester 0.2-0.3 Jojoba oil and other oily components 4.0-5.0 Polypeptide derived from silk fiber 5.5-8.0 Carboxy Methyl chitin 3.0-4.5 Sodium lactate
3.0-4.5 Pyrrolidone carbon ugliness 1.7-2.3 Glucose and fructose 3.5-4.5 Carboxy vinyl polymer Purified water Balance Each of the above formulations has a surface for emulsifying oily components. No activators are used.
カルボキシメチルキチン、ポリペプタイド等はソジウム
・モンモリロナイトとそれぞれその系のなかで複合体と
なり、単独に使用するよりも保湿。Carboxymethyl chitin, polypeptide, etc. form a complex with sodium and montmorillonite in their respective systems, and are more moisturizing than when used alone.
湿潤の高い効果を得ることができる。A high moisturizing effect can be obtained.
以上
特許出願人 日軽ニュビジネス株式株式会社代表取締役
今 沢 茂 雄
特許出願人 株式会社 ゲラン開発研究所代表取締役
手 塚 煕Patent applicant: Shigeru Konzawa, Representative Director, Nikkei New Business Co., Ltd. Patent applicant: Representative Director, Guerlain Development Institute Co., Ltd.
Hiro Tezuka
Claims (1)
・モンモリロナイトの包接作用を利用し、さらに尿素・
モンモリロナイト複合体による包接作用を相乗させて、
在来の手段である各種表面活性剤を完全に使用しない基
礎化粧用クリームとその製造法に関する。 ２）油性分としては、ホホバ、グレープシード、アボカ
ド、オリーブ、サフラワー、ヒマワリ、アカデミアンナ
ッツ、等の植物油脂。各種の胚芽油。スクワラン、ミン
ク等の動物性油脂。さらにビタミンＥ、Ａ、等を使用す
る。 ３）保湿、湿潤効果を得るため、ピロリドンカルボン酸
ナトリウム、ヒアルロン酸ナトリウム、各種のグリコー
ル類、Ｌ−プロリン、乳酸、乳酸ナトリウム、さらに、
尿素、キチン誘導体の高分子多糖体、ケラチン誘導体ポ
リペプタイド類、絹繊維由来のペプタイド類を夫々のソ
ジウム・モンモリロナイト複合体を組成のなかに生成さ
せ、あるいは添加し夫々を単独にまたは混用してなる基
礎化粧用クリームとその製造法に関する。 ４）牛の真皮より酵素分解によって得られるコラーゲン
、牛の靭帯を酵素分解して得られるエラスチン、白子由
来のデオキシリボ核酸等のソジウム・モンモリロナイト
複合体を夫々または混合して添加し保水性、増粘効果、
皮膚賦活調整剤に寄与する本発明の特徴ある、基礎化粧
用クリームとその製造法に関する。[Claims] 1) As a means for uniformly dispersing oily components in an aqueous system, the inclusion action of sodium montmorillonite is utilized, and urea and montmorillonite are used.
By synergizing the inclusion effect of the montmorillonite complex,
This invention relates to a basic cosmetic cream that completely does not use various surfactants, which are conventional means, and a method for producing the same. 2) As oily components, vegetable oils such as jojoba, grapeseed, avocado, olive, safflower, sunflower, academic nuts, etc. Various germ oils. Animal fats and oils such as squalane and mink. Furthermore, vitamins E, A, etc. are used. 3) To obtain moisturizing and moisturizing effects, sodium pyrrolidone carboxylate, sodium hyaluronate, various glycols, L-proline, lactic acid, sodium lactate, and
Urea, chitin derivative polymer polysaccharides, keratin derivative polypeptides, and silk fiber-derived peptides are produced or added to the respective sodium-montmorillonite complexes, and each is used singly or in combination. Concerning basic cosmetic cream and its manufacturing method. 4) Collagen obtained by enzymatic decomposition from cow dermis, elastin obtained by enzymatic decomposition of bovine ligaments, and sodium-montmorillonite complexes such as deoxyribonucleic acid derived from milt are added individually or in combination to improve water retention and viscosity. effect,
The present invention relates to a basic cosmetic cream that contributes to a skin activation regulator and a method for producing the same.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP63198941A JPH0249711A (en) | 1988-08-11 | 1988-08-11 | Novel cream for foundation cosmetic |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP63198941A JPH0249711A (en) | 1988-08-11 | 1988-08-11 | Novel cream for foundation cosmetic |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| JPH0249711A true JPH0249711A (en) | 1990-02-20 |
Family
ID=16399515
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP63198941A Pending JPH0249711A (en) | 1988-08-11 | 1988-08-11 | Novel cream for foundation cosmetic |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JPH0249711A (en) |
Cited By (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB2307176A (en) * | 1995-11-15 | 1997-05-21 | Todd Selwyn Everest | Anti-inflammatory clathrating agents for topical use |
| JP2001151636A (en) * | 1999-09-09 | 2001-06-05 | Mitsuko Sawada | Pack for cosmetic and production thereof |
| JP2004203896A (en) * | 1999-09-09 | 2004-07-22 | Mitsuko Sawada | Pack for makeup and method for producing the same |
| JP2009184936A (en) * | 2008-02-04 | 2009-08-20 | Kiyomi Seida | Composition for gum |
| JP2011105621A (en) * | 2009-11-13 | 2011-06-02 | Nof Corp | Hyaluronidase activity inhibitor and external preparation for skin |
| JPWO2014157265A1 (en) * | 2013-03-28 | 2017-02-16 | ロート製薬株式会社 | Emulsified external composition |
-
1988
- 1988-08-11 JP JP63198941A patent/JPH0249711A/en active Pending
Cited By (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB2307176A (en) * | 1995-11-15 | 1997-05-21 | Todd Selwyn Everest | Anti-inflammatory clathrating agents for topical use |
| JP2001151636A (en) * | 1999-09-09 | 2001-06-05 | Mitsuko Sawada | Pack for cosmetic and production thereof |
| JP2004203896A (en) * | 1999-09-09 | 2004-07-22 | Mitsuko Sawada | Pack for makeup and method for producing the same |
| JP2009184936A (en) * | 2008-02-04 | 2009-08-20 | Kiyomi Seida | Composition for gum |
| JP2011105621A (en) * | 2009-11-13 | 2011-06-02 | Nof Corp | Hyaluronidase activity inhibitor and external preparation for skin |
| JPWO2014157265A1 (en) * | 2013-03-28 | 2017-02-16 | ロート製薬株式会社 | Emulsified external composition |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CA2339290C (en) | Reaction products of hyaluronic acid and natural amino acids and their use in cosmetic and pharmaceutical compositions | |
| FR2787326B1 (en) | NANOEMULSION BASED ON FATTY ESTERS OF GLYCEROL, AND ITS USES IN THE COSMETIC, DERMATOLOGICAL AND / OR OPHTHALMOLOGICAL FIELDS | |
| FR2787728B1 (en) | NANOEMULSION BASED ON FATTY ESTERS OF PHOSPHORIC ACID, AND ITS USES IN THE COSMETIC, DERMATOLOGICAL, PHARMACEUTICAL AND / OR OPHTHALMOLOGICAL FIELDS | |
| KR20010005971A (en) | Cosmetic and/or dermatological composition containing a derivative of methylated silanol and a derivative of hydrolysed plant protein | |
| EP1140199A1 (en) | Hyaluronate lyase used for promoting penetration in topical agents | |
| JPH03502919A (en) | Cosmetic agents and skin treatment compositions | |
| JPH0230733B2 (en) | ||
| KR101817765B1 (en) | Skin whitening cosmetic compositions | |
| US4963656A (en) | Emulsified compositions containing elastin hydrolysate | |
| JP3249844B2 (en) | Skin cosmetics | |
| JPH0249711A (en) | Novel cream for foundation cosmetic | |
| EP1173145A1 (en) | Composition for cosmetic and dermatological skin care | |
| JP4777645B2 (en) | Collagen synthesis promoter and collagen metabolism activator | |
| JP3596953B2 (en) | Whitening cosmetics | |
| JPS5920212A (en) | Emulsified composition | |
| JP2011042613A (en) | Anti-aging skin care preparation and anti-aging cosmetic | |
| JPH0435212B2 (en) | ||
| JPS61210013A (en) | External preparation for skin | |
| JP2769321B2 (en) | External preparation | |
| JPH08198741A (en) | Biological hyarulonic acid synthesis promoter | |
| JP2620770B2 (en) | External preparation for skin | |
| JP3904357B2 (en) | Method for producing cosmetic emulsion containing no synthetic surfactant | |
| JP2001139447A (en) | Skin cosmetic comprising water-soluble i type collagen and vitamin c derivative formulated therein | |
| KR970009376B1 (en) | New sustained moisturizing lipstick comprising microcapsules which contain hyaluronic acid or its alkali metal salts, and its manufacturing process | |
| JPH0725650B2 (en) | Cosmetics containing Sodium-Montmorillonite and urea complex as main components |